Systemic autologous lymphocyte transfer can enhance tumor-infiltrating lymphocyte infiltration in glioblastoma and license co-stimulatory immunotherapy

被引：0
|
作者：
Singh, Kirit
Hotchkiss, Kelly M.
Moelker, Eliese
Archer, Gary E.
Sampson, John H.
Khasraw, Mustafa
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4061
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4061
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Preclinical development of tumor-infiltrating lymphocyte (TIL) based adoptive cell transfer (ACT) immunotherapy for patients with sarcoma and the potential benefit of anti-CD137 stimulation.
    Nielsen, Morten
    Krarup-Hansen, Anders
    Hovgaard, Dorrit
    Petersen, Michael Mork
    Loya, Anand Chainsukh
    Westergaard, Marie Christine Wulff
    Svane, Inge Marie
    Junker, Niels
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [42] QuPath versus InForm: Digital image analysis of multiplex immunofluorescence (mIF) tumor-infiltrating lymphocyte (TIL) outcomes in an immunotherapy clinical trial.
    Nikitin, Benjamin M.
    Chun, Brie
    Kim, Isaac
    Redmond, William L.
    Sanchez, Katherine
    Sun, Zhaoyu
    Wu, Yaping
    Page, David B.
    CANCER RESEARCH, 2021, 81 (13)
  • [43] ASO Visual Abstract: Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
    Sawada, Ryuichiro
    Akiyoshi, Takashi
    Kitagawa, Yusuke
    Hiyoshi, Yukiharu
    Mukai, Toshiki
    Nagasaki, Toshiya
    Yamaguchi, Tomohiro
    Konishi, Tsuyoshi
    Yamamoto, Noriko
    Ueno, Masashi
    Fukunaga, Yosuke
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 406 - 407
  • [44] ASO Visual Abstract: Systemic Inflammatory Markers Combined with Tumor-Infiltrating Lymphocyte Density for the Improved Prediction of Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
    Ryuichiro Sawada
    Takashi Akiyoshi
    Yusuke Kitagawa
    Yukiharu Hiyoshi
    Toshiki Mukai
    Toshiya Nagasaki
    Tomohiro Yamaguchi
    Tsuyoshi Konishi
    Noriko Yamamoto
    Masashi Ueno
    Yosuke Fukunaga
    Annals of Surgical Oncology, 2021, 28 : 406 - 407
  • [45] Divergent transcriptional states and kinetics of circulating tumor-infiltrating lymphocyte repertoires with highly homologous T-cell receptor sequences in a patient during immunotherapy
    Kajihara, Ryutaro
    Long, Mark D.
    Hoki, Toshifumi
    Chen, Hongbin
    Yamauchi, Takayoshi
    Kanemaru, Hisashi
    Segal, Brahm H.
    Dy, Grace K.
    Ito, Fumito
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (01)
  • [46] Advancements in Melanoma Treatment: A Review of PD-1 Inhibitors, T-VEC, mRNA Vaccines, and Tumor-Infiltrating Lymphocyte Therapy in an Evolving Landscape of Immunotherapy
    Mehta, Apoorva
    Motavaf, Mateen
    Nebo, Ikenna
    Luyten, Sophia
    Osei-Opare, Kofi D.
    Gru, Alejandro A.
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (04)
  • [47] The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration
    Takemoto, N
    Konishi, F
    Yamashita, K
    Kojima, M
    Furukawa, T
    Miyakura, Y
    Shitoh, K
    Nagai, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (02) : 90 - 98
  • [48] Triggering co-stimulation directly in melanoma tumor fragments drives CD8+ tumor-infiltrating lymphocyte expansion with improved effector-memory properties
    Chacon, Jessica Ann
    Sarnaik, Amod A.
    Pilon-Thomas, Shari
    Radvanyi, Laszlo
    ONCOIMMUNOLOGY, 2015, 4 (12):
  • [49] PHASE 2 EFFICACY AND SAFETY OF AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTE (TIL) CELL THERAPY IN COMBINATION WITH PEMBROLIZUMAB IN IMMUNE CHECKPOINT INHIBITOR-NAIVE PATIENTS WITH ADVANCED CANCERS
    O'Malley, David
    Lee, Sylvia
    Psyrri, Amanda
    Sukari, Ammar
    Thomas, Sajeve
    Wenham, Robert
    Gogas, Helen
    Jazaeri, Amir
    Monk, Bradley
    Rose, Peter
    Reuda, Antonio
    Finckenstein, Friedrich Graf
    Jagasia, Madan
    Fiaz, Rana
    Garelik, Brigid
    Shi, Wen
    Desai, Anjali
    Sulur, Giri
    Chen, Guang
    Wu, Xiao
    Jimeno, Antonio
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A523 - A524
  • [50] Efficacy and safety of lifileucel, an investigational autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma previously treated with anti-LAG3 antibody
    Larkin, J.
    Dalle, S.
    Sanmamed, M. F.
    Wilson, M.
    Hassel, J. C.
    Kluger, H.
    Orloff, M.
    Weber, J. S.
    Finckenstein, F. Graf
    Hari, P.
    Jagasia, M.
    Yin, H.
    Shi, W.
    Sulur, G.
    Wu, X.
    Gontcharova, V.
    Lewis, K.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S935 - S936
12345